More than 114,000 people are waiting for organs in the U.S. and fewer than 35,000 organs were transplanted last year. Transplant centers want to make sure donated organs aren't wasted.
A third of all pharmaceutical spending in the U.S. will be on so-called rare-disease medicines in 2020, leading many to wonder whether the Orphan Drug Act may have overcorrected.
Hospitalizations of nursing home residents, while decreasing in recent years, remain a problem, with nearly 11% of patients in 2016 being sent to hospitals for conditions that might have been averted with better medical oversight.
Coupled with other ongoing efforts by the Trump administration to gut Obamacare, policy experts predict the ideas would further foster a parallel market of cheaper, less robust coverage that could draw younger or healthier consumers, but drive up premiums for those who...
Critics of the practice say that device reps attend surgeries to strengthen their relationships with particular surgeons and thereby persuade them to choose one brand of artificial hip joint or stent or pacemaker over a competitor's.
Nationwide, navigator groups are scrambling to make up for the loss of federal funding to ensure they can help people make sense of their health insurance options.
Even in a world of soaring drug prices, multiple sclerosis medicines stand out. Over two decades, costs for MS medicines rose five to seven times faster than those for prescription drugs generally.
